These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27690270)

  • 1. Hepatotoxicity prediction by systems biology modeling of disturbed metabolic pathways using gene expression data.
    Carbonell P; Lopez O; Amberg A; Pastor M; Sanz F
    ALTEX; 2017; 34(2):219-234. PubMed ID: 27690270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotoxicity Prediction by Systems Biology Modeling of Disturbed Metabolic Pathways Using Gene Expression Data.
    López-Massaguer O; Pastor M; Sanz F; Carbonell P
    Methods Mol Biol; 2018; 1800():505-518. PubMed ID: 29934908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward preclinical predictive drug testing for metabolism and hepatotoxicity by using in vitro models derived from human embryonic stem cells and human cell lines - a report on the Vitrocellomics EU-project.
    Mandenius CF; Andersson TB; Alves PM; Batzl-Hartmann C; Björquist P; Carrondo MJ; Chesne C; Coecke S; Edsbagge J; Fredriksson JM; Gerlach JC; Heinzle E; Ingelman-Sundberg M; Johansson I; Küppers-Munther B; Müller-Vieira U; Noor F; Zeilinger K
    Altern Lab Anim; 2011 May; 39(2):147-71. PubMed ID: 21639679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro transcriptomic prediction of hepatotoxicity for early drug discovery.
    Cheng F; Theodorescu D; Schulman IG; Lee JK
    J Theor Biol; 2011 Dec; 290():27-36. PubMed ID: 21884709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicant-Induced Metabolic Alterations in Lipid and Amino Acid Pathways Are Predictive of Acute Liver Toxicity in Rats.
    Pannala VR; Estes SK; Rahim M; Trenary I; O'Brien TP; Shiota C; Printz RL; Reifman J; Shiota M; Young JD; Wallqvist A
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the zebrafish embryo as an alternative model for the evaluation of liver toxicity by histopathology and expression profiling.
    Driessen M; Kienhuis AS; Pennings JL; Pronk TE; van de Brandhof EJ; Roodbergen M; Spaink HP; van de Water B; van der Ven LT
    Arch Toxicol; 2013 May; 87(5):807-23. PubMed ID: 23559145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach.
    Ebbels TM; Keun HC; Beckonert OP; Bollard ME; Lindon JC; Holmes E; Nicholson JK
    J Proteome Res; 2007 Nov; 6(11):4407-22. PubMed ID: 17915905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations.
    Albrecht W; Kappenberg F; Brecklinghaus T; Stoeber R; Marchan R; Zhang M; Ebbert K; Kirschner H; Grinberg M; Leist M; Moritz W; Cadenas C; Ghallab A; Reinders J; Vartak N; van Thriel C; Golka K; Tolosa L; Castell JV; Damm G; Seehofer D; Lampen A; Braeuning A; Buhrke T; Behr AC; Oberemm A; Gu X; Kittana N; van de Water B; Kreiling R; Fayyaz S; van Aerts L; Smedsrød B; Ellinger-Ziegelbauer H; Steger-Hartmann T; Gundert-Remy U; Zeigerer A; Ullrich A; Runge D; Lee SML; Schiergens TS; Kuepfer L; Aguayo-Orozco A; Sachinidis A; Edlund K; Gardner I; Rahnenführer J; Hengstler JG
    Arch Toxicol; 2019 Jun; 93(6):1609-1637. PubMed ID: 31250071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both cholestatic and steatotic drugs trigger extensive alterations in the mRNA level of biliary transporters in rat hepatocytes: Application to develop new predictive biomarkers for early drug development.
    Donato MT; López-Riera M; Castell JV; Gómez-Lechón MJ; Jover R
    Toxicol Lett; 2016 Nov; 263():58-67. PubMed ID: 27765674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria.
    Jones DP; Lemasters JJ; Han D; Boelsterli UA; Kaplowitz N
    Mol Interv; 2010 Apr; 10(2):98-111. PubMed ID: 20368370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity.
    Cosgrove BD; King BM; Hasan MA; Alexopoulos LG; Farazi PA; Hendriks BS; Griffith LG; Sorger PK; Tidor B; Xu JJ; Lauffenburger DA
    Toxicol Appl Pharmacol; 2009 Jun; 237(3):317-30. PubMed ID: 19362101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Potential Risk of Drugs to Induce Hepatotoxicity in Human-Relationships between Hepatic Steatosis Observed in Non-Clinical Toxicity Study and Hepatotoxicity in Humans.
    Goda K; Kobayashi A; Takahashi A; Takahashi T; Saito K; Maekawa K; Saito Y; Sugai S
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inroads to predict in vivo toxicology-an introduction to the eTOX Project.
    Briggs K; Cases M; Heard DJ; Pastor M; Pognan F; Sanz F; Schwab CH; Steger-Hartmann T; Sutter A; Watson DK; Wichard JD
    Int J Mol Sci; 2012; 13(3):3820-3846. PubMed ID: 22489185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
    O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
    Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-Scale Characterization of Toxicity-Induced Metabolic Alterations in Primary Hepatocytes.
    Rawls KD; Blais EM; Dougherty BV; Vinnakota KC; Pannala VR; Wallqvist A; Kolling GL; Papin JA
    Toxicol Sci; 2019 Dec; 172(2):279-291. PubMed ID: 31501904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.
    Godoy P; Hewitt NJ; Albrecht U; Andersen ME; Ansari N; Bhattacharya S; Bode JG; Bolleyn J; Borner C; Böttger J; Braeuning A; Budinsky RA; Burkhardt B; Cameron NR; Camussi G; Cho CS; Choi YJ; Craig Rowlands J; Dahmen U; Damm G; Dirsch O; Donato MT; Dong J; Dooley S; Drasdo D; Eakins R; Ferreira KS; Fonsato V; Fraczek J; Gebhardt R; Gibson A; Glanemann M; Goldring CE; Gómez-Lechón MJ; Groothuis GM; Gustavsson L; Guyot C; Hallifax D; Hammad S; Hayward A; Häussinger D; Hellerbrand C; Hewitt P; Hoehme S; Holzhütter HG; Houston JB; Hrach J; Ito K; Jaeschke H; Keitel V; Kelm JM; Kevin Park B; Kordes C; Kullak-Ublick GA; LeCluyse EL; Lu P; Luebke-Wheeler J; Lutz A; Maltman DJ; Matz-Soja M; McMullen P; Merfort I; Messner S; Meyer C; Mwinyi J; Naisbitt DJ; Nussler AK; Olinga P; Pampaloni F; Pi J; Pluta L; Przyborski SA; Ramachandran A; Rogiers V; Rowe C; Schelcher C; Schmich K; Schwarz M; Singh B; Stelzer EH; Stieger B; Stöber R; Sugiyama Y; Tetta C; Thasler WE; Vanhaecke T; Vinken M; Weiss TS; Widera A; Woods CG; Xu JJ; Yarborough KM; Hengstler JG
    Arch Toxicol; 2013 Aug; 87(8):1315-530. PubMed ID: 23974980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity.
    Kostadinova R; Boess F; Applegate D; Suter L; Weiser T; Singer T; Naughton B; Roth A
    Toxicol Appl Pharmacol; 2013 Apr; 268(1):1-16. PubMed ID: 23352505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrated approach to improved toxicity prediction for the safety assessment during preclinical drug development using Hep G2 cells.
    Noor F; Niklas J; Müller-Vieira U; Heinzle E
    Toxicol Appl Pharmacol; 2009 Jun; 237(2):221-31. PubMed ID: 19332084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of potential hepatotoxicity induced by drugs.
    Gómez-Lechón MJ; Lahoz A; Gombau L; Castell JV; Donato MT
    Curr Pharm Des; 2010 Jun; 16(17):1963-77. PubMed ID: 20236064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term chronic toxicity testing using human pluripotent stem cell-derived hepatocytes.
    Holmgren G; Sjögren AK; Barragan I; Sabirsh A; Sartipy P; Synnergren J; Björquist P; Ingelman-Sundberg M; Andersson TB; Edsbagge J
    Drug Metab Dispos; 2014 Sep; 42(9):1401-6. PubMed ID: 24980256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.